Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Theories of Dissolution: Diffusion Layer Model01:15

Theories of Dissolution: Diffusion Layer Model

Dissolution, the process by which drug particles dissolve in a solvent, is explained by the diffusion layer model, a theoretical framework that simulates the absorption of oral drugs and allows us to analyze experimental data.
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Keap1-Kelch-targeting protein-protein interaction inhibitors, but not reversibly-binding electrophiles, increase the thermostability of Keap1 in the cellular environment.

RSC chemical biology·2026
Same author

Overcoming the Challenges of Viscous Simulated Fed State Media with a Computerized Numerical Control Tablet Disintegration and Dissolution Tester.

AAPS PharmSciTech·2026
Same author

Effect of pH on small-molecule inhibitor binding to influenza virus hemagglutinin.

The Journal of biological chemistry·2026
Same author

Hydrophobic tagging: A promising paradigm for targeted protein degradation.

Cell insight·2026
Same author

Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses.

Journal of medicinal chemistry·2026
Same author

Small molecule drug discovery for Ebola virus disease.

RSC medicinal chemistry·2025

Related Experiment Video

Updated: Jul 17, 2026

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution
09:59

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

Studies of variability in dissolution testing with USP apparatus 2.

Zongming Gao1, Terry W Moore, Anjanette P Smith

  • 1Division of Pharmaceutical Analysis, Center for Drug Evaluation and Research, Food and Drug Administration, St. Louis, Missouri 63101, USA. zongming.gao@fda.hhs.gov

Journal of Pharmaceutical Sciences
|January 26, 2007
PubMed
Summary

Sample tablets contribute the most variance in dissolution testing, not apparatus or operators. Tablet position within the dissolution vessel also significantly impacts results, highlighting areas for improved measurement system variability analysis.

More Related Videos

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

Related Experiment Videos

Last Updated: Jul 17, 2026

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution
09:59

Coherent anti-Stokes Raman Scattering (CARS) Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

Area of Science:

  • Pharmaceutical Science
  • Analytical Chemistry
  • Quality Control

Background:

  • Dissolution testing is critical for pharmaceutical quality control.
  • Understanding measurement system variability is essential for reliable drug product assessment.
  • USP Apparatus 2 is a widely used method for dissolution testing.

Purpose of the Study:

  • To quantify variability in USP Apparatus 2 dissolution testing.
  • To identify sources of variation: apparatus, operator, and sample tablet.
  • To assess the impact of tablet position on dissolution results.

Main Methods:

  • Gauge repeatability and reproducibility (Gauge R&R) study design.
  • Nested model for analyzing destructive dissolution test data.
  • Perturbation tests with disintegrating and non-disintegrating tablets.
  • Statistical evaluation using similarity (f1) and dissimilarity (f2) factors.

Main Results:

  • Sample tablets accounted for approximately 70% of total variance.
  • Apparatus contributed approximately 25% to variance.
  • Operators accounted for only about 5% of the total variance.
  • No significant differences were found between operators or apparatuses.
  • Tablet position within the dissolution vessel significantly affected results.

Conclusions:

  • Sample tablet properties are the primary source of variability in USP Apparatus 2 dissolution testing.
  • While operators and apparatus show minimal variability, tablet positioning requires careful consideration.
  • Further investigation into tablet positioning effects is warranted for robust dissolution method development.